Synthetic tannin and polidocanol in topical therapy of allergic dermatoses in children
Open Access
- 10 October 2026
- journal article
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 14,p. 81-93
Abstract
Allergic skin diseases in young children are characterized by pronounced exudation due to anatomical immaturity of the skin, increased vascular permeability, spongiosis, and a disrupted epidermal barrier. This article describes in detail the mechanisms of immune inflammation, in which proinflammatory mediators (histamine, IL-4, IL-13, etc.) play a key role, as well as chronic itching and scratching, which creating a vicious cycle of “itching – scratching – inflammation”. The pathogenesis of exacerbations with oozing and exudation is discussed. Allergic skin diseases hold a leading place in the structure of childhood skin pathology, and the features of their course at this age – a tendency to exudation, involvement of sensitive areas, and a high risk of secondary infection – impose special requirements on topical agents, whose safety is no less important than efficacy. The properties of synthetic tannin and polidocanol, the basis of Neotanin – a barrier agent approved for use in children from the first month of life, free of hormones, antibiotics, and dyes, and acting within the stratum corneum without systemic absorption – are considered. Synthetic tannin forms a protective film on the skin surface, exerts astringent, drying, and antipruritic effects, and prevents secondary infection, while polidocanol additionally reduces itching. The authors present three clinical cases of successful treatment of allergic dermatoses in children with Neotanin – both in various combinations with topical glucocorticosteroids and as monotherapy, including lesions localized on sensitive skin areas. In all observations, regression of inflammation and relief of itching were achieved, and no adverse events were recorded.Keywords
This publication has 30 references indexed in Scilit:
- Association between skin barrier development and early-onset atopic dermatitis: A longitudinal birth cohort studyJournal of Allergy and Clinical Immunology, 2023
- Novel insights into contact dermatitisJournal of Allergy and Clinical Immunology, 2022
- Regulation of the immune response to contact sensitizers by Nrf2Contact Dermatitis, 2022
- Dysregulation of the epithelial barrier by environmental and other exogenous factorsContact Dermatitis, 2021
- Update on the Pathogenesis and Therapy of Atopic DermatitisClinical Reviews in Allergy & Immunology, 2021
- Innate Immune Mechanisms in Contact Dermatitis2021
- Atopic dermatitis: Role of the skin barrier, environment, microbiome, and therapeutic agentsJournal of Dermatological Science, 2021
- Basics and recent advances in the pathophysiology of atopic dermatitisThe Journal of Dermatology, 2020
- Topical Corticosteroid Phobia in Atopic DermatitisJAMA Dermatology, 2017
- Selective Inactivation of Human Neutrophil Elastase by Synthetic TanninJournal of Investigative Dermatology, 1991